Mind Bio was listed on the Shenzhen Stock Exchange on 2018-07-10 under the stock code 002932, so it is a deep stock.
Wuhan Mind Bio-technology Co. It is a company specializing in the provision of in vitro diagnostic reagents and supporting instrumentation products as well as the integration of acute and critical care treatment. At present, the company's main business has covered nearly 5,000 medical institutions in 30 provinces, municipalities and autonomous regions. At the same time in Asia, the European Union, South America and other regions to achieve sales layout. This time in the fight against the new crown pneumonia epidemic. Mindray Bio urgently developed the new crown nucleic acid test kit and obtained the registration certificate. Became a representative IVD enterprise in the epidemic area. At the same time. Mindray's new crown nucleic acid reagents, antibody detection reagents and blood gas analyzers also gained CE access to the European Union. Obtained the qualification of selling in foreign countries. The company is mainly engaged in the research and development, production, sales and service of in vitro diagnostic reagents and diagnostic instruments. The company's main products and services cover three major areas: in vitro diagnostic reagents and instruments, acute and critical care information solutions, third-party medical testing services.